Preview: Pieris Pharmaceuticals's Earnings

Pieris Pharmaceuticals PIRS is set to give its latest quarterly earnings report on Tuesday, 2021-11-02. Here's what investors need to know before the announcement.

Analysts estimate that Pieris Pharmaceuticals will likely report an Earnings Per Share (EPS) of $-0.24

Pieris Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed on EPS by -3.85%, which was followed by a 3.01% increase in the share price the next day.

Here's a look at Pieris Pharmaceuticals's past performance and the resulting price change:

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate -0.26 -0.17 -0.24 -0.13
EPS Actual -0.25 -0.07 -0.26 -0.26
Price Change % 3.01% 0.0% 2.8% 1.5%

eps graph

Stock Performance

Shares of Pieris Pharmaceuticals were trading at $4.58 as of October 29. Over the last 52-week period, shares are up 76.4%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

If you want to track all upcoming earnings announcements, check out our Earnings Calendar here

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-EP
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!